Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT02808104

Public ClinicalTrials.gov record NCT02808104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)

Study identification

NCT ID
NCT02808104
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NLS Pharmaceutics
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

  • mazindol Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2016
Primary completion
Mar 27, 2017
Completion
Mar 27, 2017
Last update posted
Apr 5, 2017

2016 – 2017

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
AVIDA Clinic Newport Beach California 92660
CNS Healthcare Jacksonville Florida 32256
South Shore Psychiatric Services Marshfield Massachusetts 02050
Rochester Center for Behavorial Medicine Rochester Hills Michigan 48307
Midwest Research Group / St. Charles Psychiatric Associates Saint Charles Missouri 63304
Clinical Neuroscience Solutions Memphis Tennessee 38119
Memorial Park Psychiatry / Bayou City Research Houston Texas 77007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02808104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02808104 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →